文献速递主动脉外科

Extent I 胸腹主动脉修复术后结局:聚焦遗传性主动脉疾病

Outcomes After Extent I Thoracoabdominal Aortic Repair: Focus on Heritable Aortic Disease.
PubMed 文献 · Ann Thorac Surg · 2023-10-21

该回顾性研究纳入1990至2022年接受Extent I胸腹主动脉修复术的992例患者,其中遗传性胸主动脉疾病(HTAD)177例(17.8%)。HTAD患者手术死亡率(1.7% vs 7.0%,P=.01)和复合不良事件率(2.8% vs 12.3%,P<.001)均低于非HTAD患者,且修复失败无生存期更优(P<.001)。作者认为开放手术对HTAD患者有效,支持优先选择开放修复。

要点

  • HTAD患者手术死亡率1.7%,非HTAD患者7.0%(P=.01)。
  • HTAD患者复合不良事件率2.8%,非HTAD患者12.3%(P<.001)。
  • HTAD患者修复失败无生存期显著优于非HTAD患者(P<.001)。

核心结论

  • 开放Extent I胸腹主动脉修复术在HTAD患者中有效,手术死亡率和不良事件率低,远期生存更好,长期耐久性优良,作者认为这为优先选择开放修复提供了有力论据。

研究设计与样本

  • 回顾性研究,纳入1990至2022年接受Extent I胸腹主动脉修复术的992例患者,中位年龄67岁(四分位距57-73岁),按是否存在HTAD分层,HTAD患者177例(17.8%)。

主要发现

  • HTAD患者手术死亡率为1.7%,非HTAD患者为7.0%(P=.01)。
  • HTAD患者复合不良事件率为2.8%,非HTAD患者为12.3%(P<.001)。
  • HTAD患者出院回家比例为92.6%,非HTAD患者为76.9%(P<.001)。
  • 手术死亡预测因素包括年龄增长、主动脉夹层、烟草使用、慢性症状和破裂;不良事件预测因素包括年龄增长、急性症状、慢性夹层和破裂。
  • HTAD患者修复失败无生存期显著优于非HTAD患者(P<.001)。

关键数值与推荐

  • HTAD定义:存在遗传性主动脉病或发病年龄≤50岁;HTAD组中35%(177例中62例)为马方综合征。

临床怎么用

  • 作者认为,开放Extent I胸腹主动脉修复术在HTAD患者中有效,手术死亡率和不良事件率低,远期生存更好,长期耐久性优良,这为优先选择开放修复提供了有力论据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Crawford extent I thoracoabdominal aortic aneurysm (TAAA) repairs are increasingly performed by an endovascular approach, including in patients with heritable thoracic aortic disease (HTAD). We evaluated outcomes after open extent I TAAA repair in patients with and without HTAD. METHODS: This retrospective study included 992 patients (median age, 67 years; quartile 1-quartile 3, 57-73 years) who underwent extent I TAAA (1990-2022), stratified by the presence of HTAD (n = 177 [17.8%]). Patients with HTAD had genetic aortopathies or presented at age ≤50 years, and 35% (62 of 177) had Marfan syndrome. Logistic regression was used to identify predictors of operative death and adverse event, a composite of operative death and persistent (present at discharge) stroke, paraplegia, paraparesis, and renal failure necessitating dialysis. Long-term outcomes were analyzed with competing risks analysis. RESULTS: Patients with HTAD had lower rates of operative mortality (1.7% vs 7.0%, P = .01) and composite adverse event (2.8% vs 12.3%, P < .001) than non-HTAD patients. Most HTAD patients were discharged home (92.6% vs 76.9%, P < .001). Predictors of operative death were increasing age, aortic dissection, tobacco use, chronic symptoms, and rupture. Predictors for adverse event were increasing age, acute symptoms, chronic dissection, and rupture. Patients with HTAD had substantially better repair-failure-free survival (P < .001). CONCLUSIONS: Open extent I TAAA repair was effective in patients with HTAD, with low operative mortality and adverse event rates, better late survival, and excellent long-term durability, making a compelling argument for preferring open repair in these patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Rebello KR, Green SY, Etheridge GM, et al. Outcomes After Extent I Thoracoabdominal Aortic Repair: Focus on Heritable Aortic Disease. Ann Thorac Surg. 2023. PMID: 37866646. doi:10.1016/j.athoracsur.2023.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。